{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:25:48Z","timestamp":1764739548230,"version":"3.46.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Operational Research and Innovation Grant of Cipto Mangunkusumo Hospital, Indonesia in 2025","award":["YR.02.01\/D.IX\/2711\/2025"],"award-info":[{"award-number":["YR.02.01\/D.IX\/2711\/2025"]}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Currently, the successfulness of reducing seizures through the selection of appropriate antiepileptic drugs (AED) in children with drug-resistant epilepsy remains a challenge due to variability characteristic in patients. This study aims to develop and evaluate machine learning models to treatment success in pediatric patients with drug-resistant epilepsy. This study will be conducted with an ambispective cohort. A total of 215 subjects will be taken from patients in Cipto Mangunkusumo Referral Hospital and Harapan Kita Child and Mother Hospital Jakarta, Indonesia. Supporting examinations will be also performed such as electroencephalography (EEG) and modified HARNESS Magnetic Resonance Imaging (MRI). The collected data will be analyzed by machine learning with several algorithms including support vector machine (SVM), decision tree (DT), random forest (RF), gradient boosting (GB), and their performance will be compared to determine the best model. This is the first study to utilize machine learning by integrating clinical data, EEG, MRI, and medication history to predict treatment success in pediatric patients with drug-resistant epilepsy in Indonesia. The developed model is expected to serve as a clinical decision supporting tool for pediatric neurologists to predict seizure control in children with DRE and determine appropriate therapeutic adjustments with more aggressively when uncontrolled seizures are predicted.<\/jats:p>","DOI":"10.3389\/fneur.2025.1701755","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:20:42Z","timestamp":1764739242000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Developing a machine learning model to assist in predicting treatment success in children with drug-resistant epilepsy"],"prefix":"10.3389","volume":"16","author":[{"given":"Achmad","family":"Rafli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wisnu Ananta","family":"Kusuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setyo","family":"Handryastuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irawan","family":"Mangunatmadja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahmad","family":"Mulyadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aria","family":"Kekalih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anggi","family":"Gayatri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Herini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e20163908","DOI":"10.1542\/peds.2016-3908","article-title":"Incidence and prevalence of childhood epilepsy: a nationwide cohort study","volume":"139","author":"Aaberg","year":"2017","journal-title":"Pediatrics"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.22037\/ijcn.v17i1.33814","article-title":"Causes and risk factors of drug-resistant epilepsy in children","volume":"17","author":"Nasiri","year":"2023","journal-title":"Iran J Child Neurol"},{"key":"ref6","author":"Mangunatmadja","year":"2023"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1212\/CON.0000000000000712","article-title":"Antiepileptic drug treatment of epilepsy in children","volume":"25","author":"Moosa","year":"2019","journal-title":"Continuum"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.3390\/ijms26094035","article-title":"Antiepileptic drug combinations for epilepsy: mechanisms, clinical strategies, and future prospects","volume":"26","author":"Li","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21037\/pm-21-26","article-title":"Application of artificial intelligence (AI) and machine learning (ML) in pediatric epilepsy: a narrative review","volume":"5","author":"Kim","year":"2022","journal-title":"Pediatr Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3174\/ajnr.A7911","article-title":"Predicting drug treatment outcomes in children with tuberous sclerosis complex\u2013related epilepsy: a clinical Radiomics study","volume":"44","author":"Hu","year":"2023","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"106888","DOI":"10.1016\/j.eplepsyres.2022.106888","article-title":"Machine learning model to predict the efficacy of antiseizure medications in patients with familial genetic generalized epilepsy","volume":"181","author":"Wu","year":"2022","journal-title":"Epilepsy Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"107040","DOI":"10.1016\/j.eplepsyres.2022.107040","article-title":"Machine learning and statistic analysis to predict drug treatment outcome in pediatric epilepsy patients with tuberous sclerosis complex","volume":"188","author":"Zhao","year":"2022","journal-title":"Epilepsy Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1111\/bcp.13720","article-title":"Personalized prediction model for seizure-free epilepsy with levetiracetam therapy: a retrospective data analysis using support vector machine","volume":"84","author":"Zhang","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/s12909-023-04698-z","article-title":"Revolutionizing healthcare: the role of artificial intelligence in clinical practice","volume":"23","author":"Alowais","year":"2023","journal-title":"BMC Med Educ"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.3390\/s23094178","article-title":"A comprehensive review on machine learning in healthcare industry: classification, restrictions, opportunities and challenges","volume":"23","author":"An","year":"2023","journal-title":"Sensors"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.yebeh.2018.04.003","article-title":"Clinical and electrocorticographic response to antiepileptic drugs in patients treated with responsive stimulation","volume":"83","author":"Skarpaas","year":"2018","journal-title":"Epilepsy Behav"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"106649","DOI":"10.1016\/j.eplepsyres.2021.106649","article-title":"A multivariable prediction model of a major treatment response for focal-onset seizures: a post-hoc analysis of phase III trials of perampanel","volume":"174","author":"Krauss","year":"2021","journal-title":"Epilepsy Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4274\/jpr.galenos.2019.93276","article-title":"Six clinical predictors for intractable childhood epilepsy","volume":"6","author":"Ay\u00e7a","year":"2019","journal-title":"J Pediatr Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0887-8994(02)00416-2","article-title":"Etiology and clinical predictors of intractable epilepsy","volume":"27","author":"Chawla","year":"2002","journal-title":"Pediatr Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.pediatrneurol.2012.09.008","article-title":"Predictors of intractable childhood epilepsy","volume":"48","author":"Seker Yilmaz","year":"2013","journal-title":"Pediatr Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jpsychores.2006.07.018","article-title":"Clinical predictors of intractable childhood epilepsy","volume":"61","author":"Gururaj","year":"2006","journal-title":"J Psychosom Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3906\/sag-2010-27","article-title":"Clinical predictors of drug-resistant epilepsy in children","volume":"51","author":"Karao\u011flu","year":"2021","journal-title":"Turk J Med Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3892\/mmr.2020.10999","article-title":"Genetic variations associated with pharmacoresistant epilepsy","volume":"21","author":"C\u00e1rdenas-Rodr\u00edguez","year":"2020","journal-title":"Mol Med Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025277","article-title":"Genetic factors and the risk of drug-resistant epilepsy in young children with epilepsy and neurodevelopment disability: a prospective study and updated meta-analysis","volume":"100","author":"Lin","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1684\/epd.2020.1174","article-title":"MRI essentials in epileptology: a review from the ILAE imaging taskforce","volume":"22","author":"Wang","year":"2020","journal-title":"Epileptic Disord"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.3390\/jcm11164657","article-title":"Epilepsy in pediatric patients\u2014evaluation of brain structures\u2019 volume using VolBrain software","volume":"11","author":"Wo\u017aniak","year":"2022","journal-title":"J Clin Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.5213\/inj.2142166.083","article-title":"Current pharmacologic strategies for treatment of intractable epilepsy in children","volume":"25","author":"Moon","year":"2021","journal-title":"Int Neurourol J"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1212\/wnl.56.11.1445","article-title":"Early development of intractable epilepsy in children","volume":"56","author":"Berg","year":"2001","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/biomedicines9050470","article-title":"Pharmacological and therapeutic approaches in the treatment of epilepsy","volume":"9","author":"Ghosh","year":"2021","journal-title":"Biomedicine"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"107966","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol Rev"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.nrl.2014.04.012","article-title":"Drug-resistant epilepsy: definition and treatment alternatives","volume":"30","author":"L\u00f3pez Gonz\u00e1lez","year":"2015","journal-title":"Neurologia"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1528-1167.2009.02238.x","article-title":"Rational polytherapy","volume":"50","author":"French","year":"2009","journal-title":"Epilepsia"},{"key":"ref34","first-page":"278","volume-title":"Buku ajar neurologi anak Vol. I","author":"Soetomenggolo","year":"2021"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.yebeh.2015.12.039","article-title":"Changing the approach to treatment choice in epilepsy using big data","volume":"56","author":"Devinsky","year":"2016","journal-title":"Epilepsy Behav"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1701755\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:20:42Z","timestamp":1764739242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1701755\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":35,"alternative-id":["10.3389\/fneur.2025.1701755"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1701755","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"article-number":"1701755"}}